Unethical Behavior of Pharmaceutical Companies

Malpractices of pharmaceutical companies in marketing their products are widely becoming common. These practices not only involve the pharmaceutical companies but are also associated with other professions. These may include nurses, doctors, technicians, pharmacists, and cosmetic sellers, among others. Traders of pharmaceutical companies give these professionals handsome incentives and subtly ask them to market their products without letting them know about the actual performance of the product whether it is a drug, cosmetic product, food, etc. Such products can have many damaging side effects ranging from minor to major. They can even sell their low-cost products by doubling the actual retail price just to have some extra money. Such practices compromise the doctoral-patient relationship of trust and mutual understanding and thus raise questions on the sanctity of the healthcare system. This piece of literature has been created to discuss issues related to the unethical behavior of pharmaceutical companies. The data shed light on the required steps for mainstreaming ethical practices. It is required to implement proper ethical guidelines within each sector of healthcare, primarily the pharmaceutical domain.

Keywords: Cardiac arrhythmias, Drug side effects, Glaxo smith kline, Pharmaceutical companies, The food and drug association, World health organization.